Pyk2 antibody | knockout validation | Cell Signaling 3480

This is a knockout-validated antibody summary, based on the publication "Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG2a

Company: Cell Signaling

Antibody: Pyk2

Catalog number: 3480

Summary: Mouse monoclonal IgG2a against a GST-Pyk2 fusion protein containing residues surrounding the carboxy-terminal of human Pyk2. Reacts with human and mouse. Suitable for western blot and immunoprecipitation.

Validation Method

Western blot

Sample

Brain cortex and hippocampus from WT and Pyk2−/− mice.

Blocking agent

Blocking buffer for fluorescent Western blotting (Rockland MB-070-010) at room temperature for 1 h.

Primary incubation

1:1,000 dilution overnight at 4°C.

Secondary incubation

Appropriate secondary antibodies (Odyssey donkey anti-mouse IRDye 680 or 800 conjugates, LI-COR Biosciences for 1 h at room temperature.

Detection

LI-COR Odyssey infrared imaging system.

Figure

Synaptic protein expression profile in cortex and hippocampus from 12-month-old WT and Pyk2−/− mice. Please see Figure 2g in the article [1].

References
  1. Salazar S, Cox T, Lee S, Brody A, Chyung A, Haas L, et al. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss. J Neurosci. 2019;39:758-772 pubmed publisher